C9Orf72 Deficient Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
C9Orf72 Deficient Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
C9orf72-Deficient Neurons are neurons with reduced expression or function of the C9orf72 protein, most commonly due to hexanucleotide repeat expansion in the C9orf72 gene. This is the most common genetic cause of both ALS and frontotemporal dementia (FTD).
The C9orf72 hexanucleotide repeat expansion (HRE) is the most frequent genetic cause of:
Normal: <25 repeats
Pathogenic: >30-60 repeats (commonly hundreds to thousands)
The expansion leads to:
Three toxic mechanisms from the expansion:
C9orf72-deficient neurons contain:
Toxic dipeptide repeats:
C9orf72 regulates:
C9orf72 deficiency in motor neurons leads to:
Neuronal deficits include:
ASOs targeting C9orf72:
C9Orf72 Deficient Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of C9Orf72 Deficient Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.